{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:48:51Z","timestamp":1787168931873,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Dermatol Online J"],"published-print":{"date-parts":[[2023]]},"DOI":"10.4103\/idoj.idoj_299_22","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T03:35:05Z","timestamp":1678419305000},"page":"221","source":"Crossref","is-referenced-by-count":1,"title":["Bimatoprost versus clobetasol propionate in scalp alopecia areata: A prospective non-randomized open-label clinical trial"],"prefix":"10.4103","volume":"14","author":[{"given":"Mohan","family":"Bhusal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Bhattarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binita","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PrashannaR","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GC","family":"Sagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-5178.371510-1","unstructured":"Messenger AG. Alopecia areata. In: Griffiths CEM, Barker J, Bleiker T, Chalmers R, Creamer D, editors. Rook's Textbook of Dermatology. 9th ed. Oxford: Blackwell Science; 2016. p. 27. 28-34."},{"key":"key-10.4103\/2229-5178.371510-2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/1346-8138.13933","article-title":"Management of alopecia areata: Updates and algorithmic approach","author":"Lee","year":"2017","journal-title":"J Dermatol"},{"key":"key-10.4103\/2229-5178.371510-3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000371416","article-title":"Bimatoprost versus mometasone furoate in the treatment of scalp alopecia areata: A pilot study","author":"Zaher","year":"2015","journal-title":"Dermatology"},{"key":"key-10.4103\/2229-5178.371510-4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1177\/1090820X13495887","article-title":"Patient-reported outcomes of bimatoprost for eyelash growth: Results from a randomized, double-masked, vehicle-controlled, parallel-group study","author":"Fagien","year":"2013","journal-title":"Aesthet Surg J"},{"key":"key-10.4103\/2229-5178.371510-5","first-page":"419","article-title":"An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects","author":"Borchert","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/2229-5178.371510-6","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jaad.2011.05.026","article-title":"A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia","author":"Blume-Peytavi","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.371510-7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1096\/fj.12-218156","article-title":"The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias","author":"Khidhir","year":"2013","journal-title":"FASEB J"},{"key":"key-10.4103\/2229-5178.371510-8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/09546634.2017.1330527","article-title":"Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata","author":"El-Ashmawy","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"key-10.4103\/2229-5178.371510-9","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jaad.2016.08.042","article-title":"SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss","author":"Olsen","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.371510-10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines\u2013Part II.National Alopecia Areata Foundation","author":"Olsen","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.371510-11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/13543784.2017.1303480","article-title":"Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia","author":"Barr\u00f3n-Hern\u00e1ndez","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"key":"key-10.4103\/2229-5178.371510-12","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1111\/pde.12920","article-title":"Successful treatment of pediatric alopecia areata of the scalp using topical bimatoprost","author":"Li","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"key-10.4103\/2229-5178.371510-13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1067\/mjd.2003.423","article-title":"Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis\/universalis","author":"Tosti","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.371510-14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/0974-7753.82123","article-title":"Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata","author":"Kuldeep","year":"2011","journal-title":"Int J Trichology"},{"key":"key-10.4103\/2229-5178.371510-15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4103\/0974-7753.111223","article-title":"A study to evaluate the efficacy of various topical treatment modalities for alopecia areata","author":"Sardesai","year":"2012","journal-title":"Int J Trichology"},{"key":"key-10.4103\/2229-5178.371510-16","unstructured":"Allergan. Safety and efficacy study of bimatoprost in the treatment of women with female pattern hair loss. In. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US); 2000. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01325350 NLM Identifier: NCT013 25350. [Last accessed on 2019 Dec 01]."},{"key":"key-10.4103\/2229-5178.371510-17","unstructured":"Allergan. Safety and efficacy study of bimatoprost in the treatment of men with androgenic alopecia. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US); 2000. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01325337 NLM Identifier: NCT01325337. [Last accessed on 2019 Nov 12]."},{"key":"key-10.4103\/2229-5178.371510-18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaad.2008.08.029","article-title":"Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata","author":"Roseborough","year":"2009","journal-title":"J Am Acad Dermatol"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:45:55Z","timestamp":1787165155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_299_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"alternative-id":["371510"],"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_299_22","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}